Skip to main content

Breadcrumb

  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective." measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.
No Filters Selected
          For the filters below, open and close each one at a time for the best experience
          CBE ID Title Steward Endorsement Cycle Status Sort descending Date of Last Endorsement Decision
          2721e Screening for Reduced Visual Acuity and Referral in Children Centers for Medicare & Medicaid Services Approval for Trial Use Removed
          2764e Fixed-dose Combination of Hydralazine and Isosorbide Dinitrate Therapy for Self-identified Black or African American Patients with Heart Failure and LVEF <40% on ACEI or ARB and Beta-blocker Therapy National Minority Quality Forum Approval for Trial Use Removed
          2550e Gout: ULT Therapy (Recommended for eMeasure Trial Approval) American College of Rheumatology Approval for Trial Use Removed
          2983e Potassium Sample Hemolysis in the Emergency Department Cleveland Clinic Approval for Trial Use Removed
          2522 Rheumatoid Arthritis: Tuberculosis Screening (Recommended for eMeasure Trial Approval) American College of Rheumatology Approved for Trial Use
          3687e ePC-07 Severe Obstetric Complications The Joint Commission Approved for Trial Use
          2525 Rheumatoid Arthritis: Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (Reccomended for eMeasure Trial Approval) American College of Rheumatology Approved for Trial Use
          2549e Gout: Serum Urate Target (Recommended for eMeasure Trial Approval) American College of Rheumatology Approved for Trial Use
          3059e One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk American Gastroenterological Association Approved for Trial Use
          0679 Percent of High Risk Residents with Pressure Ulcers (Long Stay) Centers for Medicare & Medicaid Services Endorsed